Trials / Sponsors / InDex Pharmaceuticals
InDex Pharmaceuticals
Industry · 4 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Terminated | The Efficacy and Safety of Cobitolimod in Participants With Moderate to Severe Active Left-Sided Ulcerative Co Ulcerative Colitis | Phase 3 | 2021-11-24 |
| Unknown | Pharmacokinetics of Cobitolimod Enemas in Participants With Active Ulcerative Colitis Ulcerative Colitis | Phase 1 | 2021-11-22 |
| Completed | The Efficacy of Cobitolimod in Patients With Moderate to Severe Active Ulcerative Colitis Ulcerative Colitis | Phase 2 | 2017-06-21 |
| Completed | The Efficacy and Safety of Cobitolimod (Kappaproct®) in Chronic Active Treatment Refractory Ulcerative Colitis Colitis, Ulcerative | Phase 3 | 2011-12-01 |